A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma - Quiz - MDSpire

A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma

  • By

  • Sveva Castelli

  • Tim Flaadt

  • Franziska Schulze

  • Theresa M. Thole-Kliesch

  • Felix Zirngibl

  • Lena Oevermann

  • Annette Künkele

  • Kathy Astrahantseff

  • Stefanie Schulte

  • Louisa Duell

  • Joerg Fuchs

  • Thorsten Simon

  • Barbara Hero

  • Patrick Hundsdoerfer

  • Julian M. M. Rogasch

  • Peter Lang

  • Steven Warmann

  • Arend von Stackelberg

  • Johannes H. Schulte

  • Angelika Eggert

  • Hedwig E. Deubzer

  • May 29, 2026

  • 0 min

Share

Original Source(s)

A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma

  • by Sveva Castelli, Tim Flaadt, Franziska Schulze, Theresa M. Thole-Kliesch, Felix Zirngibl, Lena Oevermann, Annette Künkele, Kathy Astrahantseff, Stefanie Schulte, Louisa Duell, Joerg Fuchs, Thorsten Simon, Barbara Hero, Patrick Hundsdoerfer, Julian M. M. Rogasch, Peter Lang, Steven Warmann, Arend von Stackelberg, Johannes H. Schulte, Angelika Eggert, Hedwig E. Deubzer

  • May 29, 2026

Related Content

Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen

Financial Hardship and Nonadherence to Lifestyle and Surveillance in Childhood Cancer Survivors

Reduced-intensity versus intensive induction in high-risk acute promyelocytic leukemia: a systematic review and meta-analysis